Integer Holdings Co. (NYSE:ITGR) Receives Average Rating of “Moderate Buy” from Analysts

Integer Holdings Co. (NYSE:ITGR) has earned a consensus rating of “Moderate Buy” from the eight research firms that are covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 12 month price target among analysts that have covered the stock in the last year is $149.00.

ITGR has been the subject of a number of recent analyst reports. Citigroup raised their price objective on Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a research report on Wednesday, December 11th. Benchmark lifted their price target on Integer from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Friday, February 21st. KeyCorp lifted their price target on Integer from $144.00 to $154.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Wells Fargo & Company reaffirmed an “overweight” rating and set a $160.00 price target on shares of Integer in a research report on Tuesday, December 3rd. Finally, Truist Financial lifted their price target on Integer from $147.00 to $163.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th.

Hedge Funds Weigh In On Integer

A number of institutional investors have recently modified their holdings of the stock. Wealth Enhancement Advisory Services LLC purchased a new position in shares of Integer during the 4th quarter valued at about $208,000. Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of Integer during the 4th quarter valued at about $7,889,000. Brucke Financial Inc. purchased a new position in shares of Integer during the 4th quarter valued at about $564,000. Azzad Asset Management Inc. ADV raised its stake in shares of Integer by 4.9% during the 4th quarter. Azzad Asset Management Inc. ADV now owns 12,138 shares of the medical equipment provider’s stock valued at $1,609,000 after buying an additional 566 shares during the last quarter. Finally, Vise Technologies Inc. increased its stake in shares of Integer by 8.3% in the 4th quarter. Vise Technologies Inc. now owns 4,702 shares of the medical equipment provider’s stock valued at $623,000 after purchasing an additional 362 shares in the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Integer Stock Down 0.4 %

Integer stock opened at $118.87 on Wednesday. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09. The stock has a market capitalization of $4.00 billion, a price-to-earnings ratio of 35.38, a PEG ratio of 1.72 and a beta of 1.24. Integer has a 1-year low of $107.11 and a 1-year high of $146.36. The business has a fifty day moving average price of $133.56 and a 200-day moving average price of $132.61.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share for the quarter, missing analysts’ consensus estimates of $1.46 by ($0.03). The business had revenue of $449.50 million during the quarter, compared to analyst estimates of $446.28 million. Integer had a return on equity of 11.65% and a net margin of 6.92%. Equities research analysts forecast that Integer will post 6.01 EPS for the current fiscal year.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.